Vor Ort
Merkzettel Warenkorb
Produktbild: Peptide Receptors, Part I
- 31%

Peptide Receptors, Part I

Aus der Reihe Handbook of Chemical Neuroanatomy
31% sparen

177,99 € UVP 261,50 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

08.06.2000

Herausgeber

A. Bjorklund + weitere

Verlag

Elsevier Science & Technology

Maße (B/H)

18,2/25,7 cm

Gewicht

1560 g

Sprache

Englisch

ISBN

978-0-444-82972-6

Beschreibung

Rezension

"This is an optimal way for a newcomer to the field to learn the subject and a good reference for any neuroscientist. I have no hesitation recommending it in the highest terms." --Doody's

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

08.06.2000

Herausgeber

Verlag

Elsevier Science & Technology

Maße (B/H)

18,2/25,7 cm

Gewicht

1560 g

Sprache

Englisch

ISBN

978-0-444-82972-6

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Weitere Artikel finden Sie in
  • Produktbild: Peptide Receptors, Part I
  • I. Somatostatin receptors. (P. Dournaud, A. Slama, A. Beaudet, J. Epelbaum). 1. Introduction. 2. Structural and biochemical properties. 3. Localization of somatostatin binding sites in central nervous system. 4. Localization of somatostatin receptor subtypes. 4.1. sst1 receptor. 4.2. sst2 receptor. 4.3. sst3 receptor. 4.4. sst4 receptor. 4.5. sst5 receptor. 5. Somatostatin receptors in brain disorders. 5.1. Brain tumors. 5.2. Alzheimer's disease. 5.3. Epilepsy. 6. Perspectives. 7. Abbreviations. 8. Acknowledgements. 9. References. II. Brain PACAP/VIP receptors: regional distribution, functional properties and physiological relevance. (P.J. Magistretti, L. Journot, J. Bockaert, J.-L. Martin). 1. Introduction. 1.1. Biosynthesis of VIP and PACAP. 1.2. VIP and PACAP binding sites. 2. Distribution of VIP and PACAP receptors. 2.1. Autoradiographic distribution of VIP binding sites in rodent brain. 2.2. Distribution of PACAP binding sites in rat brain. 2.3. Comparison between the distribution of VIP and PACAP binding sites. 3. Molecular cloning and pharmacological characterization of VIP/PACAP receptors. 3.1. VPAC1 and VPAC2: two genes, two receptors. 3.2. PAC1: one gene, seven receptors (at least). 3.3. Pharmacology. 3.4. Distribution of VPAC1 and VPAC2 receptors in rat brain. 3.5. Distribution of PAC1 receptor mRNA. 4. Signal transduction. 4.1. VPAC1, VPAC2: two receptors, one effector. 4.2. PAC1: seven receptors, two effectors. 4.3. Agonist-directed PAC1 receptor trafficking of PLC stimulation. 4.4. Additional PAC1 receptor signal transduction. 5. Trophic actions of VIP and PACAP. 5.1. Neurotrophic actions elicited by VIP. 5.2. Stimulation of early embryonic growth by VIP. 5.3. VIP protects against excitotoxic cell death. 5.4. Neurotrophic and anti-apoptotic properties of PACAP. 6. Involvement of VIP/PACAP in circadian rhythms and sleep. 6.1. Involvement of VIP/PACAP in circadian rhythms. 6.2. VIP and PACAP are involved in sleep regulation. 7. Regulation of brain energy metabolism by VIP. 7.1. Regulation by VIP of genes controlling glycogen metabolism. 8. Modulation by VIP and PACAP of glutamate-mediated signalling in the cerebral cortex. 8.1. VIP and PACAP potentiate the glutamate-evoked release of arachidonic acid. 8.2. VIP and PACAP potentiate the actions of glumate on BDNF and c-fos expression. 9. Abbreviations. 10. Acknowledgements. 11. References. III. Localization of angiotensin receptors in the nervous system. (A.M. Allen, B.J. Oldfield, M.E. Giles, G. Paxinos, M.J. McKinley, F.A.O. Mendelsohn) 1. Introduction. 1.1. Renin-angiotensin system. 1.2. Renin-angiotensin system in the brain. 1.3. Angiotensin receptors. 2. Localization of AT1 and AT2 receptors. 2.1. Localization by autoradiography or hybridization histochemistry. 2.2. Distribution of AT1 and AT2 receptors in the rat brain. 2.3. Immunohistochemical detection of AT1 receptors. 2.4. The distribution of AT1 and AT2 receptors in other species. 3. Overview of AT1 receptor functions in selected brain regions. 3.1. The lamina terminalis. 3.2. The hypothalamic paraventricular nucleus. 3.3. The dorsal vagal complex. 3.4. The ventrolateral medulla. 4. Conclusion. 5. Abbreviations. 6. Acknowledgements. 7. References. IV. Brain endothelin and natriuretic peptide receptors. (J.M. Saavedra, A.M. De Oliveira, O. Jöhren, L. Tonelli.) 1. Why endothelin and natriuretic receptors? 2. Brain endothelin receptors. 2.1. Endothelin. 2.2. Distribution of endothelins. 2.3. Endothelin receptors. 2.4. Quantification of endothelin receptors and their subtypes. 2.5. How many receptor subtypes. 2.6. Distribution of ET receptors. 2.7. Functions of endothelin receptors in the brain. 3. Brain natriuretic peptide receptors. 3.1. Natriuretic peptides. 3.2. Distribution of natriuretic peptides in the brain. 3.3. Natriure